FACIT and Triphase Accelerator Announce New Partnership with Celgene

FACIT and Triphase Accelerator announced a new strategic collaboration with Celgene for a first-in-class pre-clinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia.

Click here to learn more

Previous
Previous

TopSpin Technologies Wins NFL Pitch Competition

Next
Next

Reviewing OBIO’s C-Suite Pub Night